{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:12:08Z","timestamp":1776420728663,"version":"3.51.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s10157-011-0409-1","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T11:47:53Z","timestamp":1297770473000},"page":"424-429","source":"Crossref","is-referenced-by-count":14,"title":["Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency"],"prefix":"10.1007","volume":"15","author":[{"given":"Przemys\u0142aw","family":"Miarka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Idzior-Walu\u015b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Ku\u017aniewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Walu\u015b-Miarka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Klupa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W\u0142adys\u0142aw","family":"Su\u0142owicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"key":"409_CR1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-2275(20)37433-2","volume":"38","author":"JA Kuivenhoven","year":"1997","unstructured":"Kuivenhoven JA, Pritchard H, Hill J, Frohlich J, Assmann G, Kastelein J. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res. 1997;38:191\u2013205.","journal-title":"J Lipid Res"},{"key":"409_CR2","first-page":"261","volume-title":"Lipoproteins in health and disease","author":"PJ Barter","year":"1999","unstructured":"Barter PJ, Rye KA. Lecithin:cholesterol acyltransferase. In: Betteridge DJ, Ilingworth DR, Shepherd J, editors. Lipoproteins in health and disease. London: Arnold; 1999. p. 261\u201376."},{"key":"409_CR3","first-page":"799","volume-title":"Lipoproteins in health and disease","author":"P Pritchard","year":"1999","unstructured":"Pritchard P, Hill J. Genetic disorders of lecithin cholesterol acyltransferase. In: Betteridge DJ, Ilingworth DR, Shepherd J, editors. Lipoproteins in health and disease. London: Arnold; 1999. p. 799\u2013814."},{"key":"409_CR4","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","volume":"95","author":"PJ Barter","year":"2004","unstructured":"Barter PJ, Nicholls S, Rye KA, Anantharamaian GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res. 2004;95:764\u201372.","journal-title":"Circ Res"},{"key":"409_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/ncpendmet0245","volume":"2","author":"M Navab","year":"2006","unstructured":"Navab M, Anantharamaian GM, Redally ST, Van Lenten BJ, Ansell BJ, Fogelman AM. Mechanisms of disease proatherogenic HDL\u2014an evolving field. Pract Endocrinol Metab. 2006;2:504\u201311.","journal-title":"Pract Endocrinol Metab"},{"key":"409_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1172\/JCI31608","volume":"117","author":"M Reilly","year":"2007","unstructured":"Reilly M, Tall A. HDL proteomics: pot of gold or Pandora\u2019s box? J Clin Invest. 2007;117:595\u20138.","journal-title":"J Clin Invest"},{"key":"409_CR7","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1172\/JCI26206","volume":"117","author":"T Vaisar","year":"2007","unstructured":"Vaisar T, Pennathur S, Green SP, Gharib SA, Hoofnagle A, Cheung MC, et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Iinvest. 2007;117:746\u201356.","journal-title":"J Clin Iinvest"},{"key":"409_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1159\/000046287","volume":"21","author":"S Homma","year":"2001","unstructured":"Homma S, Murayama N, Yoshida I, Kusano E, Kuriki K, Saito K, et al. Marked atherosclerosis in a patient with familiar lecithin:cholesterol acyltransferase deficiency associated with end-stage renal disease and diabetes mellitus. Am J Nephrol. 2001;21:415\u20139.","journal-title":"Am J Nephrol"},{"key":"409_CR9","first-page":"411","volume":"51","author":"LK Borysiewicz","year":"1982","unstructured":"Borysiewicz LK, Soutar AK, Evans DJ, Thompson GR, Rees AJ. Renal failure in familial lecithin:cholesterol acyltransferase deficiency. Q J Med. 1982;51:411\u201326.","journal-title":"Q J Med"},{"key":"409_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000167056","volume":"5","author":"E Imbasciati","year":"1986","unstructured":"Imbasciati E, Paties C, Scarpioni L, Mihatsch MJ. Renal lesions in familial lecithin-cholesterol acyltransferase deficiency: ultrastructural heterogeneity of glomerular changes. Am J Nephrol. 1986;5:66\u201370.","journal-title":"Am J Nephrol"},{"key":"409_CR11","first-page":"331","volume":"4","author":"DJ Lager","year":"1991","unstructured":"Lager DJ, Rosenberg BF, Shapiro H, Bernstein J. Lecithin-cholesterol acyltransferase deficiency: ultrastructural examination of sequential renal biopsies. Mod Pathol. 1991;4:331\u20135.","journal-title":"Mod Pathol"},{"key":"409_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000167056","volume":"6","author":"E Inbasciati","year":"1986","unstructured":"Inbasciati E, Paties C, Scarpioni L, Mihatsch MJ. Renal lesions in familial lecithin-cholesterol acyltransferase deficiency. Am J Nephrol. 1986;6:66.","journal-title":"Am J Nephrol"},{"key":"409_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000046001","volume":"88","author":"A Sessa","year":"2001","unstructured":"Sessa A, Battini G, Meroni M, Daidone G, Carnera I, Brambilla PL, et al. Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations. Nephron. 2001;88:268\u201372.","journal-title":"Nephron"},{"key":"409_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.atherosclerosis.2005.06.022","volume":"185","author":"B Idzior-Walus","year":"2006","unstructured":"Idzior-Walus B, Sieradzki J, Kostner G, Ma\u0142ecki M, Klupa T, Weso\u0142owska T, et al. Familial lecithin-cholesterol acyltransferase deficiency: biochemical characteristics and molecular analysis of a new LCAT mutation in a Polish family. Atherosclerosis. 2006;185:413\u201320.","journal-title":"Atherosclerosis"},{"key":"409_CR15","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1046\/j.1523-1755.2001.060002520.x","volume":"60","author":"EG Lynn","year":"2001","unstructured":"Lynn EG, Siow YL, Frohlich J, Cheung GT. O.K. Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B. Kidney Int. 2001;60:520\u201332.","journal-title":"Kidney Int"},{"key":"409_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1023\/A:1006865420286","volume":"175","author":"EG Lynn","year":"1997","unstructured":"Lynn EG, Choy PC, Magil A, O K. Uptake and metabolism of lipoprotein-X in mesangial cells. Mol Cell Biochem 1997;175:187\u201394.","journal-title":"Mol Cell Biochem"},{"key":"409_CR17","doi-asserted-by":"publisher","first-page":"15090","DOI":"10.1074\/jbc.M008466200","volume":"276","author":"G Lambert","year":"2001","unstructured":"Lambert G, Sakai N, Vaisman BL, Neufeld EB, Marteyn B, Chan CC, et al. Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. J Biol Chem. 2001;276:15090\u20138.","journal-title":"J Biol Chem"},{"key":"409_CR18","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0002-9440(10)63386-X","volume":"165","author":"X Zhu","year":"2004","unstructured":"Zhu X, Herzenberg AM, Eskandarian M, Maguire GF, Scholey JW, Connelly PW, et al. Novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy Am J Pathol 2004;165:1269-1278.","journal-title":"Am J Pathol"},{"key":"409_CR19","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1161\/01.ATV.19.3.794","volume":"19","author":"S Jimi","year":"1999","unstructured":"Jimi S, Uesugi N, Saku K, Itabe H, Zhang B, Arakawa K, et al. Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli. Arterioscler Thromb Vasc Biol. 1999;19:794\u2013801.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"409_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/ki.1985.167","volume":"28","author":"WG Couser","year":"1985","unstructured":"Couser WG. Mechanisms of glomerular injury in immune-complex disease. Kidney Int. 1985;28:569\u201383.","journal-title":"Kidney Int"},{"key":"409_CR21","unstructured":"Appel GB. Glomerular disorders. In: Goldman L, Ausiello D, editors. Cecil Textbook of Medicine. Philadelphia: Saunders; 2004; 726-33."},{"key":"409_CR22","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0002-9440(10)64614-7","volume":"157","author":"T Christainsen-Weber","year":"2000","unstructured":"Christainsen-Weber T, Voland JR, Wu Y, Ngo K, Roland BL, et al. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am J Pathol. 2000;157:1017\u201329.","journal-title":"Am J Pathol"},{"key":"409_CR23","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/ndt\/gfm233","volume":"22","author":"CL Weber","year":"2007","unstructured":"Weber CL, Frohlich J, Wang J, Hegele RA, Chan-Yan C. Stability of peritoneal dialysis in a patient with familial LCAT deficiency. Nephrol Dial Transplant. 2007;22:2084\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"409_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.atherosclerosis.2008.11.033","volume":"205","author":"MS Yee","year":"2009","unstructured":"Yee MS, Pavitt DV, Richmond W, Cook HT, McLean AG, Valabhii J, et al. Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy. Atherosclerosis. 2009;205:528\u201332.","journal-title":"Atherosclerosis"},{"key":"409_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5414\/CNP69213","volume":"69","author":"P Aranda","year":"2008","unstructured":"Aranda P, Valdivielso P, Pisciotta L, Garcia I, Garc\u00e3 A-Arias C, Bertolini S, et al. Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs). Clin Nephrol. 2008;69:213\u20138.","journal-title":"Clin Nephrol"},{"key":"409_CR26","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1111\/j.1523-1755.2005.00266.x","volume":"67","author":"B Javaid","year":"2005","unstructured":"Javaid B, Quigg RJ. Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics? Kidney Int. 2005;67:1692\u2013703.","journal-title":"Kidney Int"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-011-0409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-011-0409-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-011-0409-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-011-0409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:18:58Z","timestamp":1637281138000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-011-0409-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1007\/s10157-011-0409-1","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}